FDA 483 - IDT Biologika GmbH - September 08, 2023

IDT Biologika GmbH, a vaccine manufacturer in Dessau-Rosslau, Germany, was cited for five significant deficiencies during an FDA inspection. These observations include releasing products before completing required tests, inadequate environmental monitoring, and issues with the suitability and verification of testing methods. Additionally, the firm was found to have deficiencies in its GMP training program and its system for ensuring the integrity and security of backup data.